Details of the Drug

General Information of Drug (ID: DMJSSGD)

• Drug Name: Beclamide
• Synonyms: Beclamide; 501-68-8; Chlorakon; Chloracon; Neuracen; N-Benzyl-3-chloropropionamide; Beklamid; Nydrane; Nydran; Seclar; Nidrane; Benzchlorpropamide; Posedrine; Beclamid; Hibicon; Chloroethylphenamide; N-Benzyl-3-chloropropanamide; Benzylamide; Khlorakon; Benzchlorpropamid; Benzochlorpropamid; Benxchlorpropamide; Posedrin; N-(3-Chloropropionyl)benzylamine; Chloropropionamide; N-Benzyl-beta-chloropropionamide; Chlorakon (VAN); NSC 67062; Beclamidum [INN-Latin]; Propanamide, 3-chloro-N-(phenylmethyl)-; Beclamida [INN-Spanish]

Indication

Disease Entry	ICD 11	Status	REF
Psychiatric disorder	6E8Z	Approved	[1]

• Affected Organisms: Humans and other mammals
• ATC Code:
  N03AX30: Beclamide
  N03AX: Other antiepileptics
  N03A: ANTIEPILEPTICS
  N03: ANTIEPILEPTICS
  N: NERVOUS SYSTEM
• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C10H12ClNO
  Canonical SMILES: C1=CC=C(C=C1)CNC(=O)CCCl
  InChI: InChI=1S/C10H12ClNO/c11-7-6-10(13)12-8-9-4-2-1-3-5-9/h1-5H,6-8H2,(H,12,13)
  InChIKey: JPYQFYIEOUVJDU-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 10391
  ChEBI ID: CHEMBL134859
  CAS Number: 501-68-8
  UNII: F5N0ALI65V
  DrugBank ID: DB09011
  TTD ID: D00DZN
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015